Filing Details
- Accession Number:
- 0001140361-17-046221
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-14 15:46:42
- Reporting Period:
- 2017-11-08
- Accepted Time:
- 2017-12-14 15:46:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | ATYR | Biological Products, (No Disgnostic Substances) (2836) | 203435077 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1598292 | Ecor1 Capital Fund Qualified, L.p. | 409 Illinois Street San Francisco CA 94158 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-01 | 4,879 | $5.05 | 3,198,420 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-01 | 24,728 | $4.80 | 3,223,148 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2017-11-08 | 1,070 | $4.30 | 3,222,078 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-11-09 | 5,819 | $4.15 | 3,216,259 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-11-10 | 5,860 | $4.00 | 3,210,399 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-11-13 | 1,083 | $3.95 | 3,209,316 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
